SCHEMBL30248405

SCHEMBL30248405

CC(C)(C)OC(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24755492 0.89 CTSL (0.44) —
SCHEMBL29179605 0.89 CTSL (0.44) —
SCHEMBL24710112 0.89 CTSL (0.44) —
SCHEMBL24190098 0.88 — —
SCHEMBL8278850 0.88 CTSL (0.41) —
SCHEMBL8276856 0.88 — —
SCHEMBL23824539 0.88 CTSL (0.41) —
SCHEMBL23824538 0.88 CTSL (0.41) —
SCHEMBL8278581 0.88 — —
SCHEMBL29179614 0.88 CTSV (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055702-A1 MAIN PROTEASE (M PRO) INHIBITORS AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-04-06 — — WO disclosed
Send feedback